These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22067613)

  • 1. Reconstituted HDL elicits marked changes in plasma lipids following single-dose injection in C57Bl/6 mice.
    Chen Z; O'Neill EA; Meurer RD; Gagen K; Luell S; Wang SP; Ichetovkin M; Frantz-Wattley B; Eveland S; Strack AM; Fisher TS; Johns DG; Sparrow CP; Wright SD; Hubbard BK; Carballo-Jane E
    J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):315-23. PubMed ID: 22067613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of isoxazolidine or triazolidine on rat serum lipids in vivo and LDL and HDL binding and degradation in human and rodent cultured cells in vitro.
    Hall IH; Wong OT; Simlot R; Izydore RA
    Res Commun Chem Pathol Pharmacol; 1992 Sep; 77(3):327-46. PubMed ID: 1333628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro.
    Hafiane A; Bielicki JK; Johansson JO; Genest J
    PLoS One; 2015; 10(7):e0131997. PubMed ID: 26207756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
    Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM
    Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
    Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. rHDL administration increases reverse cholesterol transport in mice, but is not additive on top of ezetimibe or cholestyramine treatment.
    Maugeais C; Annema W; Blum D; Mary JL; Tietge UJ
    Atherosclerosis; 2013 Jul; 229(1):94-101. PubMed ID: 23725986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of high-density lipoprotein levels by cholesteryl ester transfer protein expression in scavenger receptor class B type I (SR-BI) knockout mice does not normalize pathologies associated with SR-BI deficiency.
    Hildebrand RB; Lammers B; Meurs I; Korporaal SJ; De Haan W; Zhao Y; Kruijt JK; Praticò D; Schimmel AW; Holleboom AG; Hoekstra M; Kuivenhoven JA; Van Berkel TJ; Rensen PC; Van Eck M
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1439-45. PubMed ID: 20431066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL2 of heavy alcohol drinkers enhances cholesterol efflux from raw macrophages via phospholipid-rich HDL 2b particles.
    Mäkelä SM; Jauhiainen M; Ala-Korpela M; Metso J; Lehto TM; Savolainen MJ; Hannuksela ML
    Alcohol Clin Exp Res; 2008 Jun; 32(6):991-1000. PubMed ID: 18498551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
    Kitayama K; Nishizawa T; Abe K; Wakabayashi K; Oda T; Inaba T; Amemiya Y
    J Pharm Pharmacol; 2006 Dec; 58(12):1629-38. PubMed ID: 17331327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional interplay between the macrophage scavenger receptor class B type I and pitavastatin (NK-104).
    Han J; Parsons M; Zhou X; Nicholson AC; Gotto AM; Hajjar DP
    Circulation; 2004 Nov; 110(22):3472-9. PubMed ID: 15557368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice.
    Tardy C; Goffinet M; Boubekeur N; Ackermann R; Sy G; Bluteau A; Cholez G; Keyserling C; Lalwani N; Paolini JF; Dasseux JL; Barbaras R; Baron R
    Atherosclerosis; 2014 Jan; 232(1):110-8. PubMed ID: 24401224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCA1-Derived Nascent High-Density Lipoprotein-Apolipoprotein AI and Lipids Metabolically Segregate.
    Xu B; Gillard BK; Gotto AM; Rosales C; Pownall HJ
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2260-2270. PubMed ID: 29074589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng.
    Yoon M; Lee H; Jeong S; Kim JJ; Nicol CJ; Nam KW; Kim M; Cho BG; Oh GT
    Br J Pharmacol; 2003 Apr; 138(7):1295-302. PubMed ID: 12711630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.
    Patel S; Drew BG; Nakhla S; Duffy SJ; Murphy AJ; Barter PJ; Rye KA; Chin-Dusting J; Hoang A; Sviridov D; Celermajer DS; Kingwell BA
    J Am Coll Cardiol; 2009 Mar; 53(11):962-71. PubMed ID: 19281927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule activation of lecithin cholesterol acyltransferase modulates lipoprotein metabolism in mice and hamsters.
    Chen Z; Wang SP; Krsmanovic ML; Castro-Perez J; Gagen K; Mendoza V; Rosa R; Shah V; He T; Stout SJ; Geoghagen NS; Lee SH; McLaren DG; Wang L; Roddy TP; Plump AS; Hubbard BK; Sinz CJ; Johns DG
    Metabolism; 2012 Apr; 61(4):470-81. PubMed ID: 22001333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice.
    Chroni A; Kan HY; Shkodrani A; Liu T; Zannis VI
    Biochemistry; 2005 Mar; 44(10):4108-17. PubMed ID: 15751988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent changes in lipoprotein lipids after a single infusion of ascending doses of MDCO-216 (apoA-IMilano/POPC) in healthy volunteers and stable coronary artery disease patients.
    Kempen HJ; Gomaraschi M; Simonelli S; Calabresi L; Moerland M; Otvos J; Jeyarajah E; Kallend D; Wijngaard PLJ
    Atherosclerosis; 2016 Dec; 255():17-24. PubMed ID: 27816804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol efflux.
    Calkin AC; Drew BG; Ono A; Duffy SJ; Gordon MV; Schoenwaelder SM; Sviridov D; Cooper ME; Kingwell BA; Jackson SP
    Circulation; 2009 Nov; 120(21):2095-104. PubMed ID: 19901191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pegylation of high-density lipoprotein decreases plasma clearance and enhances antiatherogenic activity.
    Murphy AJ; Funt S; Gorman D; Tall AR; Wang N
    Circ Res; 2013 Jun; 113(1):e1-e9. PubMed ID: 23613182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A point mutant of apolipoprotein A-I, V156K, exhibited potent anti-oxidant and anti-atherosclerotic activity in hypercholesterolemic C57BL/6 mice.
    Cho KH; Park SH; Han JM; Kim HC; Chung YJ; Choi I; Kim JR
    Exp Mol Med; 2007 Apr; 39(2):160-9. PubMed ID: 17464177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.